These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 29061006)
1. [Efficacy of extended-infusion of carbapenem plus sulbactam for ventilator-associated pneumonia caused by extensive drug-resistant Wang X; Hu Y; Que CL; Zhang H; Huang JJ; Cao J; Jin Z; Wang GF; Zhang W Zhonghua Yi Xue Za Zhi; 2017 Oct; 97(38):2996-3000. PubMed ID: 29061006 [No Abstract] [Full Text] [Related]
2. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests. Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302 [TBL] [Abstract][Full Text] [Related]
3. Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia. Yilmaz GR; Guven T; Guner R; Kocak Tufan Z; Izdes S; Tasyaran MA; Acikgoz ZC J Infect Dev Ctries; 2015 May; 9(5):476-85. PubMed ID: 25989167 [TBL] [Abstract][Full Text] [Related]
4. Meropenem/colistin versus meropenem/ampicillin-sulbactam in the treatment of carbapenem-resistant pneumonia. Khalili H; Shojaei L; Mohammadi M; Beigmohammadi MT; Abdollahi A; Doomanlou M J Comp Eff Res; 2018 Sep; 7(9):901-911. PubMed ID: 30192166 [TBL] [Abstract][Full Text] [Related]
5. Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: Retrospective Comparison Between Intravenous Colistin and Intravenous Ampicillin-Sulbactam. Zalts R; Neuberger A; Hussein K; Raz-Pasteur A; Geffen Y; Mashiach T; Finkelstein R Am J Ther; 2016; 23(1):e78-85. PubMed ID: 24263165 [TBL] [Abstract][Full Text] [Related]
9. Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex. Ye JJ; Lin HS; Yeh CF; Wu YM; Huang PY; Yang CC; Huang CT; Lee MH BMC Infect Dis; 2016 Aug; 16():374. PubMed ID: 27496018 [TBL] [Abstract][Full Text] [Related]
10. Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii. Liang CA; Lin YC; Lu PL; Chen HC; Chang HL; Sheu CC Clin Microbiol Infect; 2018 Aug; 24(8):908.e1-908.e7. PubMed ID: 29108947 [TBL] [Abstract][Full Text] [Related]
11. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii. Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the treatment efficacy between tigecycline plus high-dose cefoperazone-sulbactam and tigecycline monotherapy against ventilator-associated pneumonia caused by extensively drug-resistant Acinetobacter baumannii. Qin Y; Zhang J; Wu L; Zhang D; Fu L; Xue X Int J Clin Pharmacol Ther; 2018 Mar; 56(3):120-129. PubMed ID: 29319497 [TBL] [Abstract][Full Text] [Related]